Plasma levels of chemerin were significantly higher in women, current smokers, and participants with hypertension, obesity, IR, and metabolic syndrome (P = 0.044, 0.009, 0.015, 6.52 × 10−9, 0.001, and 0.004, resp.; Table 4). Here, RARRES2 is linked to metabolic syndrome.